Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP8 | P22894 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | FPR2 | P25090 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | RRM1 | P23921 | 4/20 | 0.34 |
| ▸ | RRM2 | P31350 | 4/20 | 0.34 |
| ▸ | RRM2B | Q7LG56 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23157003 | 1.00 | MMP1 (0.39) | MMP1MMP2MMP8ALDH1A1FPR2 | |
| SCHEMBL24963372 | 0.98 | MMP1 (0.36) | MMP1MMP2MMP8FPR2RRM1 | |
| SCHEMBL24965299 | 0.98 | MMP1 (0.36) | MMP1MMP2MMP8FPR2RRM1 | |
| SCHEMBL24966043 | 0.96 | REN (0.36) | MMP1MMP2MMP8RRM1RRM2 | |
| SCHEMBL22008662 | 0.91 | POLB (0.37) | ALDH1A1 | |
| SCHEMBL23879197 | 0.83 | MEN1 (0.42) | MMP8ALDH1A1HTTTSHRGAA | |
| SCHEMBL24580423 | 0.83 | CCKBR (0.41) | MMP1MMP2MMP8HTTCPB2 | |
| SCHEMBL24966123 | 0.83 | FPR2 (0.38) | MMP1MMP2MMP8FPR2HTT | |
| SCHEMBL24965917 | 0.83 | MEN1 (0.42) | MMP8ALDH1A1HTTTSHRGAA | |
| SCHEMBL4566691 | 0.81 | MMP1 (0.41) | MMP1MMP2MMP8ALDH1A1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279928-A | Process for the preparation of cyclic compounds comprising N-substituted amino acid residues | 中外制药株式会社 | 2023-12-22 | — | — | CN | disclosed |
| US-20230295221-A1 | EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-09-21 | — | — | US | disclosed |
| CN-116615219-A | Method for producing pharmaceutical product comprising freeze-drying step using mixed solvent | 中外制药株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | disclosed |
| WO-2022138891-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | 中外製薬株式会社 | 2022-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | DNPEP, VIP, NPEPPS | MMP1 3245/4885MMP2 2333/4885MMP8 2070/4885 |
| US-20230295221-A1 | EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES | NGLY1, VIP, DNPEP | MMP1 3436/4885MMP2 2503/4885MMP8 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.